82059-51-6Relevant articles and documents
Method of lowering serum uric acid levels with (S)-tofisopam
-
Page/Page column 13, (2016/09/12)
Enantiomerically-pure (S)-tofisopam is administered to lower serum uric acid levels in a mammal.
USE OF TOFISOPAM AS A PDE10A INHIBITOR
-
Page/Page column 16-17, (2008/06/13)
The present invention relates to a novel use of Tofisopam for the preparation of a pharmaceutical composition made for treatment of the positivsymptoms and cognitive deficits in schizophrenic patients.
Method for isolating (R)-tofisopam
-
Page 14, (2008/06/13)
(R)-tofisopam, substantially free of the (S)-enantiomer of tofisopam, is obtained by separating the enantiomers of tofisopam by chromatography employing a chiral separation medium comprising (i) (2S)-2-{(1S)[(3,5-dinitrophenyl)carbonylamino]phenylmethyl}-